| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3661909
[patent_doc_number] => 05648396
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/486056
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7809
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648396.pdf
[firstpage_image] =>[orig_patent_app_number] => 486056
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486056 | Methods for treating depression and other disorders using optically pure R (-) fluoxetine and monoamine oxidase inhibitor | Jun 6, 1995 | Issued |
Array
(
[id] => 3643297
[patent_doc_number] => 05628982
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-13
[patent_title] => 'Hydroxy-aryl metal chelates for diagnostic NMR imaging'
[patent_app_type] => 1
[patent_app_number] => 8/466471
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6135
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/628/05628982.pdf
[firstpage_image] =>[orig_patent_app_number] => 466471
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466471 | Hydroxy-aryl metal chelates for diagnostic NMR imaging | Jun 5, 1995 | Issued |
Array
(
[id] => 3687125
[patent_doc_number] => 05663188
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods'
[patent_app_type] => 1
[patent_app_number] => 8/468505
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4794
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663188.pdf
[firstpage_image] =>[orig_patent_app_number] => 468505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468505 | Synergistic therapeutic compositions of angiotensin I converting enzyme inhibitors and angiotensin II antagonists and methods | Jun 5, 1995 | Issued |
Array
(
[id] => 3842631
[patent_doc_number] => 05707981
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'Synergistic pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/469371
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 36
[patent_no_of_words] => 1669
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/707/05707981.pdf
[firstpage_image] =>[orig_patent_app_number] => 469371
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469371 | Synergistic pharmaceutical compositions | Jun 5, 1995 | Issued |
Array
(
[id] => 3715717
[patent_doc_number] => 05616571
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-01
[patent_title] => 'Bisphosphonates prevent bone loss associated with immunosuppressive therapy'
[patent_app_type] => 1
[patent_app_number] => 8/471466
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1380
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/616/05616571.pdf
[firstpage_image] =>[orig_patent_app_number] => 471466
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471466 | Bisphosphonates prevent bone loss associated with immunosuppressive therapy | Jun 5, 1995 | Issued |
| 08/471111 | METHODS FOR MINIMIZING BONE LOSS | Jun 5, 1995 | Abandoned |
Array
(
[id] => 3874833
[patent_doc_number] => 05824693
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-20
[patent_title] => 'Method for treatment for pulmonary disease'
[patent_app_type] => 1
[patent_app_number] => 8/470094
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2569
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/824/05824693.pdf
[firstpage_image] =>[orig_patent_app_number] => 470094
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470094 | Method for treatment for pulmonary disease | Jun 5, 1995 | Issued |
Array
(
[id] => 1009472
[patent_doc_number] => 06900234
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-31
[patent_title] => 'Synergistic therapeutic compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 08/463878
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4817
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900234.pdf
[firstpage_image] =>[orig_patent_app_number] => 08463878
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463878 | Synergistic therapeutic compositions and methods | Jun 4, 1995 | Issued |
Array
(
[id] => 4217066
[patent_doc_number] => 06110951
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-29
[patent_title] => 'Thiazolidine derivatives for the treatment of hypertension'
[patent_app_type] => 1
[patent_app_number] => 8/463464
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10387
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/110/06110951.pdf
[firstpage_image] =>[orig_patent_app_number] => 463464
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463464 | Thiazolidine derivatives for the treatment of hypertension | Jun 4, 1995 | Issued |
Array
(
[id] => 1206064
[patent_doc_number] => 06716875
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => 'Synergistic therapeutic compositions of ACE and renin inhibitors and methods'
[patent_app_type] => B1
[patent_app_number] => 08/465660
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4808
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716875.pdf
[firstpage_image] =>[orig_patent_app_number] => 08465660
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465660 | Synergistic therapeutic compositions of ACE and renin inhibitors and methods | Jun 4, 1995 | Issued |
Array
(
[id] => 4108408
[patent_doc_number] => 06022897
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/465375
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8739
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022897.pdf
[firstpage_image] =>[orig_patent_app_number] => 465375
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465375 | Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof | Jun 4, 1995 | Issued |
Array
(
[id] => 3838771
[patent_doc_number] => 05847002
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-08
[patent_title] => 'Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID'
[patent_app_type] => 1
[patent_app_number] => 8/461123
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 7855
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/847/05847002.pdf
[firstpage_image] =>[orig_patent_app_number] => 461123
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461123 | Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and NSAID | Jun 4, 1995 | Issued |
Array
(
[id] => 3657579
[patent_doc_number] => 05622973
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates'
[patent_app_type] => 1
[patent_app_number] => 8/464982
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32279
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622973.pdf
[firstpage_image] =>[orig_patent_app_number] => 464982
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464982 | Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates | Jun 4, 1995 | Issued |
Array
(
[id] => 3648400
[patent_doc_number] => 05629318
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-13
[patent_title] => 'Method of treatment of chronic prostatitis with 17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones'
[patent_app_type] => 1
[patent_app_number] => 8/448451
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6162
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/629/05629318.pdf
[firstpage_image] =>[orig_patent_app_number] => 448451
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448451 | Method of treatment of chronic prostatitis with 17.beta.-N-monosubstituted-carbamoyl-4-aza-5.alpha.-androst-1-en-3-ones | Jun 1, 1995 | Issued |
Array
(
[id] => 3647348
[patent_doc_number] => 05637620
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Micro formoterol particles'
[patent_app_type] => 1
[patent_app_number] => 8/459660
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2857
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637620.pdf
[firstpage_image] =>[orig_patent_app_number] => 459660
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459660 | Micro formoterol particles | Jun 1, 1995 | Issued |
Array
(
[id] => 3571638
[patent_doc_number] => 05538970
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-23
[patent_title] => 'Treatment of cancer with imidazo-1,2-pyridazin compounds'
[patent_app_type] => 1
[patent_app_number] => 8/458225
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19679
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/538/05538970.pdf
[firstpage_image] =>[orig_patent_app_number] => 458225
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458225 | Treatment of cancer with imidazo-1,2-pyridazin compounds | Jun 1, 1995 | Issued |
| 08/458195 | USE OF ALENDRONATE FOR THE PREVENTION OF OSTEOPOROSIS | Jun 1, 1995 | Abandoned |
Array
(
[id] => 3984135
[patent_doc_number] => 05958959
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Treatment of platelet derived growth factor related disorders such as cancers'
[patent_app_type] => 1
[patent_app_number] => 8/457051
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 24
[patent_no_of_words] => 39322
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958959.pdf
[firstpage_image] =>[orig_patent_app_number] => 457051
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457051 | Treatment of platelet derived growth factor related disorders such as cancers | May 31, 1995 | Issued |
Array
(
[id] => 3829377
[patent_doc_number] => 05739138
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes'
[patent_app_type] => 1
[patent_app_number] => 8/457703
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16592
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739138.pdf
[firstpage_image] =>[orig_patent_app_number] => 457703
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457703 | Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes | May 31, 1995 | Issued |
Array
(
[id] => 3860059
[patent_doc_number] => 05792772
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Enatiomerically pure hydroxylated xanthine compounds'
[patent_app_type] => 1
[patent_app_number] => 8/458957
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16541
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792772.pdf
[firstpage_image] =>[orig_patent_app_number] => 458957
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/458957 | Enatiomerically pure hydroxylated xanthine compounds | May 31, 1995 | Issued |